Research Title: A Phase 2 Study of RO6867461 in Participants With Center-Involving Diabetic Macular Edema (CI-DME) (BOULEVARD)
Sponsor: Hoffman La-Roche
Principal Investigator: Robert Stoltz, M.D., PhD
Description: This is a multiple-center, multiple-dose, randomized, active comparator-controlled, double-masked, three parallel group, 28-week study in participants with CI-DME. Only one eye will be selected as the study eye. Where both eyes meet all eligibility criteria, the eye with the worse best corrected visual acuity (BCVA) will be defined as the study eye. Participants will be randomized into each arm group (1:1:1) and total duration of the study will be approximately 32 weeks.
Start Date: December 2016
Project Personnel: Leslie Marcus, CCRC; Halie Sklanka, CRC; Caitlin Harrison, CRC
Location(s): Marietta; 833 Campbell Hill Street, Suite 300, Marietta, GA 30060